Results 1 to 10 of about 16,939 (142)

Gut microbiota dependant trimethylamine N-oxide and hypertension

open access: yesFrontiers in Physiology, 2023
The human gut microbiota environment is constantly changing and some specific changes influence the host’s metabolic, immune, and neuroendocrine functions.
Katongo H. Mutengo   +6 more
doaj   +3 more sources

Trimethylamine N-oxide in atrial fibrillation progression

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2020
The human gut microbiome and its metabolite Trimethylamine N-oxide (TMAO) are sensitive to the human diet and are involved in the complex pathomechanisms that underpin diabetes, obesity, and cardiovascular diseases.
Petra Büttner   +7 more
doaj   +3 more sources

Role of Trimethylamine N-Oxide in Heart Failure

open access: yesReviews in Cardiovascular Medicine
Heart failure (HF) is a clinical syndrome characterizing by typical physical signs and symptomatology resulting from reduced cardiac output and/or intracardiac pressure at rest or under stress due to structural and/or functional abnormalities of the ...
Lele Jing   +6 more
doaj   +3 more sources

The microbial metabolite trimethylamine N-oxide and the kidney diseases [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology
Trimethylamine N-oxide (TMAO), a metabolite, is a co-metabolite produced by both gut microbiota and livers, originating from foods rich in choline or carnitine.
Jin-Qi Su   +15 more
doaj   +2 more sources

Trimethylamine-N-oxide and cerebral stroke risk: A review

open access: yesNeurobiology of Disease
Trimethylamine-N-oxide (TMAO) is a gut microbiota-derived metabolite produced by the action of gut microbiota and the hepatic enzyme Flavin Mono‑oxygenase 3 (FMO3).
Phurbu Dolkar   +13 more
doaj   +3 more sources

Plasma trimethylamine N-oxide (TMAO): associations with cognition, neuroimaging, and dementia

open access: yesAlzheimer’s Research & Therapy
Background The gut-derived metabolite Trimethylamine N-oxide (TMAO) and its precursors - betaine, carnitine, choline, and deoxycarnitine – have been associated with an increased risk of cardiovascular disease, but their relation to cognition ...
Amber Yaqub   +10 more
doaj   +5 more sources

Trimethylamine N-oxide—a marker for atherosclerotic vascular disease [PDF]

open access: yesReviews in Cardiovascular Medicine, 2021
As a potential causative factor in various cardiovascular diseases, the gut microbe-generated metabolite trimethylamine N-oxide (TMAO) has courted considerable research interest as a potential biomarker.
Guinan Xie   +4 more
doaj   +1 more source

Atherosclerosis and trimethylamine-N-oxide — the gut microbiota potential

open access: yesРоссийский кардиологический журнал, 2022
Gut dysbiosis contribute to the development of atherosclerosis. Firmicutes contain a trimethylamine-producing gene cluster. The aim was to analyze potential role of trimethylamine-N-oxide (TMAO), gut microbiota metabolite, in the pathogenesis of ...
I. N. Grigorieva
doaj   +1 more source

Trimethylamine N-Oxide (TMAO) and Trimethylamine (TMA) Determinations of Two Hadal Amphipods

open access: yesJournal of Marine Science and Engineering, 2022
Hadal trenches are a unique habitat with high hydrostatic pressure, low temperature and scarce food supplies. Amphipods are the dominant scavenging metazoan species in this ecosystem.
Qi Liu   +4 more
doaj   +1 more source

Fecal Microbiome Composition Does Not Predict Diet‐Induced TMAO Production in Healthy Adults

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Trimethylamine‐N‐oxide (TMAO) is a small molecule derived from the metabolism of dietary nutrients by gut microbes and contributes to cardiovascular disease. Plasma TMAO increases following consumption of red meat.
Marc Ferrell   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy